BioCardia, Inc. (BCDA) vs Clovis Oncology, Inc. (CLVSQ)
- BioCardia, Inc. BCDA 0.92 −2.13%
- Clovis Oncology, Inc. CLVSQ
BioCardia, Inc. and Clovis Oncology, Inc. are both Biotechnology companies. BioCardia, Inc. and Clovis Oncology, Inc. are of similar size ($14.2M and $14.2M). BioCardia, Inc. grew revenue faster over the last twelve months: 0.71% against −14.8%. BioCardia, Inc. has the higher net margin (0.00% vs −189.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, BioCardia, Inc. leads on 9 and Clovis Oncology, Inc. on 7.
Valuation
Profitability
| Metric | BCDA | CLVSQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 72.21% | 65.16% |
| Operating margin | 0.00% | (155.38%) | 0.00% |
| Net margin | 0.00% | (189.37%) | 0.00% |
| Free cash flow margin | 0.00% | (132.19%) | 0.00% |
| Return on equity | (1,803.19%) | 78.31% | (56.36%) |
| Return on assets | (214.47%) | (58.94%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack